Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects
- PMID: 24382309
- DOI: 10.1111/liv.12454
Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects
Abstract
Background & aims: The course of NAFLD (nonalcoholic fatty liver disease) and associated factors in nonobese subjects are not well established. We investigated contributing factors for the development and regression of NAFLD in nonobese Koreans, and whether they would differ from those of obese subjects.
Methods: Two thousand three hundred and seven adults aged over 18 years participated in this longitudinal observational study. The mean duration of follow-up was 28.7 (±13.2) months. The participants were divided into two groups according to the baseline BMI (nonobese group: BMI <25 kg/m(2), obese group: BMI ≥25 kg/m(2)). The presence or absence of NAFLD was assessed by abdominal ultrasonography.
Results: Body weight change was independently associated with both the development and regression of NAFLD in nonobese subjects as well as obese subjects. Among the subjects who developed NAFLD, the amount of weight change was higher in nonobese subjects compared to obese subjects (1.6 ± 3.9% vs 0.6 ± 4.2%, P = 0.022); and among those who showed regression of NAFLD, the amount of weight change was lower in nonobese subjects (-1.9 ± 4.0% vs -5.0 ± 4.6%, P < 0.001). Among all the components of metabolic syndrome, only high triglyceride levels (>150 mg/dl) at the baseline were significantly associated with both the development and regression of NAFLD in nonobese subjects (ORs, 1.54 (1.10-2.14), and 0.60 (0.38-0.96) respectively).
Conclusion: Body weight change and baseline triglyceride levels were strong indicators for the development and regression of NAFLD in a nonobese population.
Keywords: hypertriglyceridaemia; metabolic syndrome; nonalcoholic fatty liver disease; nonobese; weight loss.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.Arch Intern Med. 2004 Oct 25;164(19):2169-75. doi: 10.1001/archinte.164.19.2169. Arch Intern Med. 2004. PMID: 15505132
-
Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults.Sleep Breath. 2016 May;20(2):529-35. doi: 10.1007/s11325-015-1232-9. Epub 2015 Jul 15. Sleep Breath. 2016. PMID: 26174847
-
Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.Am J Gastroenterol. 2013 Aug;108(8):1299-304. doi: 10.1038/ajg.2013.104. Epub 2013 Apr 9. Am J Gastroenterol. 2013. PMID: 23567356
-
Nonobese Fatty Liver Disease.Clin Gastroenterol Hepatol. 2017 Apr;15(4):474-485. doi: 10.1016/j.cgh.2016.08.028. Epub 2016 Aug 28. Clin Gastroenterol Hepatol. 2017. PMID: 27581063 Review.
-
The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.J Clin Gastroenterol. 2020 Apr;54(4):378-387. doi: 10.1097/MCG.0000000000001270. J Clin Gastroenterol. 2020. PMID: 31651571
Cited by
-
Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population.Arch Med Sci Atheroscler Dis. 2019 Aug 6;4:e191-e195. doi: 10.5114/amsad.2019.87122. eCollection 2019. Arch Med Sci Atheroscler Dis. 2019. PMID: 31538123 Free PMC article.
-
Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.Lipids Health Dis. 2020 Oct 28;19(1):229. doi: 10.1186/s12944-020-01409-1. Lipids Health Dis. 2020. PMID: 33109219 Free PMC article.
-
Clinical value of γ-glutamyl transpeptidase to platelet ratio and triglyceride measurement in the diagnosis of nonalcoholic fatty liver disease: A cross-sectional study.Heliyon. 2024 Aug 13;10(16):e36193. doi: 10.1016/j.heliyon.2024.e36193. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39224338 Free PMC article.
-
Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease.Sci Rep. 2019 May 28;9(1):7922. doi: 10.1038/s41598-019-44453-3. Sci Rep. 2019. PMID: 31138858 Free PMC article.
-
Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.PLoS One. 2015 Dec 2;10(12):e0143851. doi: 10.1371/journal.pone.0143851. eCollection 2015. PLoS One. 2015. PMID: 26629827 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources